ADXN实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (1 May 2024 @ 04:00):

Stats
今日成交量	63 362.00
平均成交量	18 803.00
市值	22.06M
EPS	$0 ( 2024-04-04 )
下一个收益日期	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.420
ATR14	$0.0990 (1.24%)

音量相关性

長: -0.05 (neutral)

短: -0.85 (strong negative)

Signal:(46.243) Neutral

Addex Therapeutics Ltd 相关性

10 最正相关
SVAC	0.974
CVGI	0.957
CYN	0.956
MESA	0.955
DARE	0.954
WISA	0.954
MCRB	0.952
UCTT	0.952
CFRX	0.952
CURI	0.952

10 最负相关
NETE	-0.974
LDHA	-0.965
VLAT	-0.964
HORI	-0.964
LGAC	-0.96
MSDAU	-0.96
ABGI	-0.96
HCNE	-0.96
HERAU	-0.959
CRZN	-0.959

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Addex Therapeutics Ltd 相关性 - 货币/商品

-0.03
( neutral )

0.47
( neutral )

0.00
( neutral )

0.12
( neutral )

0.21
( neutral )

Addex Therapeutics Ltd 财务报表

Annual	2023
营收:	$1.61M
毛利润:	$-5.32M (-329.99 %)
EPS:	$-0.140

FY	2023
营收:	$1.61M
毛利润:	$-5.32M (-329.99 %)
EPS:	$-0.140

FY	2022
营收:	$1.42M
毛利润:	$-13.20M (-928.06 %)
EPS:	$-0.460

FY	2021
营收:	$2.92M
毛利润:	$0.00 (0.00 %)
EPS:	$-2.70

Financial Reports:

No articles found.

Addex Therapeutics Ltd

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The CharcotMarieTooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.